Videos
In this episode, David Ellison, Sebastian Bachman, and Jessica Bahena-Lopez describe how their results show that there are three cell types along the kidney thick ascending limb, enabling it to adjust solute absorption selectively to maintain homeostasis.
In this episode, Liza Makowski explains that bariatric surgery causes long term changes to our gut microbiome, which the study demonstrates could improve the body’s immune response to current breast cancer treatments.
In this episode, Jacqueline Starrett and Will Charlton describe how TYRA-300, an FGFR3-selective kinase inhibitor, increases bone growth in mouse models of achondroplasia and hypochondroplasia.
The authors thank Rob Wishnowsky of Cruxio, Inc., and Fernando de Miguel for support creating the video abstract.
In this episode, Davide Croci, Sandra van Wilpe, and Niven Mehra explain that their manuscript predicts clinical benefit to immunotherapy by analyzing combined biomarkers from circulating tumor DNA and immune cell gene expression data in blood.
In this episode, Skip Brass and Myles Akabas explain how the results of their manuscript show that none of the applicant metrics, individually or collectively, predict in-program performance, future research effort, or eventual workplace choices even when comparisons were limited to those in the top and bottom quintiles.
